SCHEMBL13051115

SCHEMBL13051115

O=S(=O)(c1ccccc1)n1cc(-c2ccnc(Cl)n2)c2ccncc21

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 10/20 0.51
▸ PDPK1 O15530 1/20 0.47
▸ DYRK1B Q9Y463 2/20 0.47
▸ CDK2 P24941 1/20 0.47
▸ DRD2 P14416 3/20 0.43
▸ HTR2A P28223 2/20 0.43
▸ HTR7 P34969 2/20 0.43
▸ HTR1A P08908 1/20 0.43
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ DYRK1A Q13627 1/20 0.41
▸ PIK3C3 Q8NEB9 2/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ FLT3 P36888 1/20 0.39
▸ CCNC P24863 1/20 0.39
▸ CDK8 P49336 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3819496 0.89 HTR6 (0.58) HTR6DRD2HTR2AHTR7HTR1A
SCHEMBL1049733 0.80 CYP2C19 (0.48) HTR6CDK2CYP3A4CYP2D6DYRK1A
SCHEMBL25422412 0.76 DYRK1B (0.48) HTR6PDPK1DYRK1BCDK2DRD2
SCHEMBL30461607 0.76 DYRK1B (0.48) HTR6PDPK1DYRK1BCDK2DRD2
SCHEMBL19337232 0.74 CCNB2 (0.44) HTR6DYRK1BCDK2DRD2HTR2A
SCHEMBL30810135 0.73 BRD4 (0.44) DYRK1BFLT3
SCHEMBL23668186 0.73 BRD4 (0.44) DYRK1BFLT3
SCHEMBL12501099 0.73 HTR6 (0.54) HTR6PDPK1CDK2DRD2HTR2A
SCHEMBL13051118 0.73 HTR6 (0.52) HTR6PDPK1DRD2HTR2AHTR7
SCHEMBL254249 0.73 HTR6 (0.52) HTR6PDPK1DRD2HTR2AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100292262-A1 4 (PYRROLO[2,3-C]PYRIDINE-3-YL)PYRIMIDIN-2-AMINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2010-11-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292262-A1 4 (PYRROLO[2,3-C]PYRIDINE-3-YL)PYRIMIDIN-2-AMINE DERIVATIVES MKI67, CDK4, CCNT1 HTR6 2359/4885PDPK1 330/4885DYRK1B 2410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback